Introduction
| Disease-Associated Microglia Type 2 (DAM2) | |
|---|---|
| Taxonomy | ID |
| Cell Ontology (CL) | [CL:0000095](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095) |
| Database | ID |
| Cell Ontology | [CL:0000095](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095) |
| Cell Ontology | [CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129) |
| Cell Ontology | [CL:0004120](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004120) |
| Gene | Expression |
| **APOE** | High |
| **TYROBP** (DAP12) | High |
| **CST7** (Cystatin F) | High |
| **ITGAX** (CD11c) | High |
| **CLECL1** | Moderate |
| **LPL** | High |
| **CD9** | High |
| Strategy | Approach |
| **TREM2 agonism** | Activate TREM2 signaling |
| **CSF1R inhibition** | Reduce microglial proliferation |
| **Lipid metabolism modulation** | Target LPL, APOE pathways |
| **CD11c targeting** | Modulate Itgax+ cells |
Disease Associated Microglia Type 2 (Dam2) is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Overview
flowchart TD
Disease_Associated_Microglia_T["Disease-Associated Microglia Type 2"]
Disease_Associated_Microglia_T["Disease-Associated"]
Disease_Associated_Microglia_T -->|"related to"| Disease_Associated_Microglia_T
style Disease_Associated_Microglia_T fill:#81c784,stroke:#333,color:#000
Disease_Associated_Microglia_T["Type"]
Disease_Associated_Microglia_T -->|"related to"| Disease_Associated_Microglia_T
style Disease_Associated_Microglia_T fill:#81c784,stroke:#333,color:#000
Disease_Associated_Microglia_T["DAM2"]
Disease_Associated_Microglia_T -->|"related to"| Disease_Associated_Microglia_T
style Disease_Associated_Microglia_T fill:#81c784,stroke:#333,color:#000
style Disease_Associated_Microglia_T fill:#4fc3f7,stroke:#333,color:#000Disease-Associated Microglia Type 2 (DAM2) represents an intermediate activation state within the disease-associated microglia (DAM) continuum. DAM2 microglia are characterized by a unique transcriptional profile that bridges the transition from homeostatic microglia (DAM0/DAM1) to the fully activated DAM phenotype. This state was identified through single-cell RNA sequencing studies of Alzheimer’s disease mouse models and is now recognized as a critical stage in microglial activation during neurodegeneration 1. 1Disease-Associated Microglia: A Universal Immune Sensor of NeurodegenerationOpen reference
The DAM2 stage represents a transitional state where microglia have: 2New insights into the role of TREM2 in Alzheimer's diseaseOpen reference
-
Lost homeostatic markers: Downregulation of P2ry12, Cx3cr1, Tmem119
-
Gained DAM markers: Upregulation of Apoe, Tyrobp, Cst7
-
Acquired disease features: Phagocytic activity, lipid metabolism changes
-
Maintained intermediate phenotype: Not yet fully activated DAM
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
-
Morphology: neuron associated cell (source: Cell Ontology)
-
Morphology can be inferred from Cell Ontology classification
-
PanglaoDB Marker Cross-References
-
Unknown (PanglaoDB):
External Database Links
Taxonomy & Classification
PanglaoDB Marker Cross-References
-
Unknown (PanglaoDB):
External Database Links
Molecular Signature
Transcriptomic Profile
DAM2 microglia express a distinct gene signature:
Surface Markers
-
CD11c (ITGAX): Hallmark marker of DAM2
-
CD9: Tetraspanin surface protein
-
MHC-II: Elevated antigen presentation
-
TREM2: Critical for DAM progression (when present)
Pathway to DAM2 Activation
Two-Step Activation Model
The progression to DAM2 follows a staged pathway:
Homeostatic (DAM0/1) → DAM1 → DAM2 → DAM1-like/DAM
↓ ↓ ↓ ↓
P2RY12+ Apoe+ Itgax+ Itgax+/-
Cx3cr1+ Tyrobp+ Cst7+ Cst7+/-
Tmem119+ Lpl+ Lpl++ Lpl+++
TREM2-Dependent and Independent Pathways
TREM2-dependent (typical DAM):
-
Requires TREM2 signaling for full activation
-
Found in AD, other neurodegenerative conditions
-
Associated with APOE-lipoprotein interaction
TREM2-independent (alternative DAM):
-
Compensatory activation without TREM2
-
Observed in TREM2 knockout conditions
-
May represent different disease contexts
Functions
Phagocytic Activity
DAM2 microglia exhibit enhanced phagocytic capacity:
-
Aβ uptake: Efficient clearance of amyloid-beta plaques
-
Synaptic pruning: Increased complement-mediated synapse elimination
-
Cell debris removal: Engulfment of dead neurons
-
Myelin phagocytosis: Observed in demyelinating conditions
Lipid Metabolism
DAM2 represents a lipid-handling state:
-
Cholesterol efflux: Upregulation of cholesterol transport genes
-
Lipid droplet formation: Accumulation of lipid droplets observed
-
Fatty acid oxidation: Increased β-oxidation pathways
-
ApoE production: Major producer of lipidated ApoE in the brain
Antigen Presentation
DAM2 microglia upregulate antigen presentation machinery:
-
MHC-II expression: Enhanced antigen presentation to CD4+ T-cells
-
Co-stimulatory molecules: CD80, CD86 upregulation
-
T-cell activation: Can activate adaptive immune responses
Role in Alzheimer’s Disease
Plaque-Associated Microglia
DAM2 microglia are prominently found surrounding amyloid plaques:
-
Plaque border localization: Concentrated at the edges of plaques
-
Plaque compaction: May contribute to plaque containment
-
Clearance activity: Attempted Aβ phagocytosis
-
Cytokine milieu: Produce both pro- and anti-inflammatory cytokines
Tau Pathology
In tauopathy models:
-
Tau uptake: Internalization of pathological tau
-
Tau propagation: Potential role in spreading tau pathology
-
Neuronal support: May attempt to protect tau-laden neurons
Neuroprotective vs. Pathogenic Role
The role of DAM2 remains controversial:
Neuroprotective aspects:
-
Aβ clearance may reduce plaque burden
-
Lipid metabolism supports neuronal health
-
Trophic factor secretion
Pathogenic aspects:
-
Excessive synaptic pruning may cause connectivity loss
-
Chronic inflammation contributes to progression
-
May represent failed clearance attempts
Therapeutic Targeting
Modulating DAM2 Activation
Biomarker Potential
DAM2-associated proteins as disease biomarkers:
-
sTREM2: Soluble TREM2 fragment, correlates with DAM activation
-
APOE: Levels in CSF/ plasma reflect microglial activation
-
YKL-40 (CHI3L1): Chitinase-like protein, inflammation marker
See Also
-
[Disease-Associated Microglia (DAM)microglia)
-
[TREM2 Signaling](/diseases/m1-polarized-microglia](/diseases)
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.